AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12745512
Drug: Nicotine inhaler
RxNorm normalized name: nicotine Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine inhaler (NI) plus placebo patch (PP) for 12 weeks, then NI alone for 14 weeks.
Trial: 8829892
Drug: Meloxicam 15
RxNorm normalized name: meloxicam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 15 mg suppositories
Trial: 8829892
Drug: Piroxicam 20
RxNorm normalized name: piroxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 20 mg suppositories
Trial: 2796625
Drug: EXACON thermal
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EXACON thermal therapy system model TT8200
Trial: 81723
Drug: Intradermal skin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal skin tests
Trial: 29271026
Drug: V-AC (vonoprazan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: V-AC (vonoprazan 20 mg bid, amoxicillin 750 mg bid, and clarithromycin 200 or 400 mg bid)
Trial: 29271026
Drug: PPI-AC (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI-AC (lansoprazole 30 mg, rabeprazole 10 mg, or esomeprazole 20 mg bid; amoxicillin 750 mg bid; and clarithromycin 200 or 400 mg bid)
Trial: 27057659
Drug: Antidepressant medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant medication for comorbid depression
Trial: 24129597
Drug: Palonosetron 0.075
RxNorm normalized name: palonosetron 0.075 MG in 1.5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.075 mg administered before induction of anaesthesia (pre-surgery group, n=50)
Trial: 24129597
Drug: Palonosetron 0.075
RxNorm normalized name: palonosetron 0.075 MG in 1.5 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.075 mg administered after surgery in the recovery room (post-surgery group, n=50)
Trial: 23017153
Drug: Continuous outpatient
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous outpatient interdisciplinary rehabilitation programme (once weekly sessions)
Trial: 20385971
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil (low-dose: 2.5 or 5 mg; high-dose: 20 or 40 mg)
Trial: 20385971
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil (continued therapy)
Trial: 18359175
Drug: 2mg oral
RxNorm normalized name: OPIPZA 2mg Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2mg oral micronized estradiol (E2) (n=25)
Trial: 18359175
Drug: 2mg oral
RxNorm normalized name: OPIPZA 2mg Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2mg oral E2 + 1mg oral norethisterone acetate (NETA) (n=28)
Trial: 16093400
Drug: Yam (Dioscorea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yam (Dioscorea alata) 390 g in 2 of 3 meals per day for 30 days
Trial: 16093400
Drug: Sweet potato
RxNorm normalized name: Sweet Potato
DrugBank: Sweet potato (DB10648)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sweet potato 240 g for 41 days (control)
Trial: 8672605
Drug: Ipsapirone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipsapirone (0.5 mg/kg orally)
Trial: 19622121
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (betamethasone dipropionate and calcipotriol)
Trial: 12872081
Drug: Suck-and-ligate device
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suck-and-ligate device without prior submucosa injection
Trial: 12872081
Drug: Cap technique
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cap technique with prior submucosa injection of dilute saline solution of epinephrine
Trial: 1525801
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (500 mg, single oral dose)
Trial: 3902675
Drug: KB-944 100
RxNorm normalized name: NF-KB Decoy
DrugBank: NF-kappaB Decoy (DB05559)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KB-944 100 mg/day
Trial: 3902675
Drug: KB-944 200
RxNorm normalized name: NF-KB Decoy
DrugBank: NF-kappaB Decoy (DB05559)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KB-944 200 mg/day
Trial: 30187284
Drug: Sodium selenite
RxNorm normalized name: Sodium selenite
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Sodium selenite (SS) 400 μg
Trial: 30187284
Drug: Se-methylselenocysteine (MSC)
RxNorm normalized name: selenomethionine Se 75
DrugBank: Selenomethionine Se-75 (DB09400)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Se-methylselenocysteine (MSC) 400 μg
Trial: 30187284
Drug: Seleno-l-methionine (SLM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seleno-l-methionine (SLM) 400 μg
Trial: 28853492
Drug: Topical aprepitant
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical aprepitant
Trial: 22129066
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment without NP diagnostics (control group, n=50)
Trial: 17505919
Drug: HAART along
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAART along with syphilis and herpes simplex virus type 2 (HSV-2) treatment
Trial: 11940726
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg/d fasting before breakfast
Trial: 11940726
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg/d fasting at noon before lunch
Trial: 1947851
Drug: ESWL treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESWL treatment by experienced surgeons (group A)
Trial: 1947851
Drug: ESWL treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ESWL treatment by inexperienced surgeons (group B)
Trial: 31365044
Drug: Estradiol patch
RxNorm normalized name: Estradiol Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol patch (200-μg)
Trial: 15642722
Drug: Red wine
RxNorm normalized name: Red wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red wine (150 ml, 15 g alcohol)
Trial: 10979918
Drug: Albendazole (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (2 sequential doses of 400 mg)
Trial: 9295004
Drug: Transdermal estradiol-17beta
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol-17beta (100 mg/day)
Trial: 8333745
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy (CDDP 50 mg/m2 + VDS 3 mg/m2)
Trial: 8333745
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy (CDDP + VDS)
Trial: 2722305
Drug: Hypnotic induction
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic induction and suggestions derived from Rational‐Emotive Therapy, 4 weekly treatment sessions
Trial: 28636208
Drug: PRN1008 (50-1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRN1008 (50-1200 mg single dose)
Trial: 28636208
Drug: PRN1008 (300-900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRN1008 (300-900 mg daily for 10 days)
Trial: 28636208
Drug: PRN1008 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRN1008 (single and multiple doses)
Trial: 26142048
Drug: H pylori
RxNorm normalized name: Helicobacter pylori
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H pylori vaccine
Trial: 24170762
Drug: Dietary fiber
RxNorm normalized name: Dietary Fiber 1.67 GM Oral Tablet, Chewable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary fiber (quartiles from 8.7 to 21.8 g)
Trial: 24170762
Drug: Vegetables and
RxNorm normalized name: Hydrogenated Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vegetables and fruits (quartiles from 228.7 to 721.4 g)
Trial: 24170762
Drug: Soluble dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble dietary fiber (per 1-g increase)
Trial: 24170762
Drug: Total dietary
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total dietary fiber (per 1-g increase)
Trial: 24170762
Drug: Insoluble dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insoluble dietary fiber (per 1-g increase)
Trial: 18335698
Drug: EpiCor (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EpiCor (500 mg daily)
Trial: 16584855
Drug: Seretide Diskus
RxNorm normalized name: seractide
DrugBank: Seractide acetate (DB09334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Seretide Diskus (salmeterol xinafoate 50 mcg; fluticasone propionate 500 mcg)
Trial: 16584855
Drug: Symbicort Turbuhaler
RxNorm normalized name: Symbicort Turbuhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Symbicort Turbuhaler (formoterol 6 mcg; budesonide 200 mcg)
Trial: 7684351
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (subcutaneous injection, single fixed daily dose)
Trial: 24522170
Drug: Once-daily insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily insulin detemir (initiated with mean 0.12 U/kg)
Trial: 24522170
Drug: Twice-daily insulin
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily insulin detemir (initiated with mean 0.12 U/kg)
Trial: 15976218
Drug: Remifentanil (Ce50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (Ce50 5.0 ng/mL) during tracheal intubation (group TI, n = 20)
Trial: 15976218
Drug: Remifentanil (Ce50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (Ce50 2.1 ng/mL) during skin incision (group SI, n = 21)
Trial: 12804052
Drug: Zevalin (ibritumomab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zevalin (ibritumomab tiuxetan) regimen including 5 mCi (111)In-labeled Zevalin on Day 1 and 0.4 mCi/kg (90)Y Zevalin on Day 8, preceded by 250 mg/m(2) rituximab.
Trial: 8347333
Drug: Physostigmine 2
RxNorm normalized name: PHYSostigmine 2 mg/5 mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine 2 mg q2h while awake for 7 days plus yohimbine 10 mg and 20 mg challenges
Trial: 8347333
Drug: Placebo q2h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo q2h while awake for 5 days plus yohimbine 10 mg and 20 mg challenges
Trial: 26501147
Drug: Aliskiren 150‐300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 150‐300 mg/d
Trial: 26501147
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) 12.5 ‐ 25 mg/d
Trial: 15591711
Drug: Trofosfamide 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trofosfamide 90 mg/m2
Trial: 15591711
Drug: Trofosfamide 125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trofosfamide 125 mg/m2
Trial: 15591711
Drug: Trofosfamide 175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trofosfamide 175 mg/m2
Trial: 15591711
Drug: Trofosfamide (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trofosfamide (all doses)
Trial: 11494446
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (MT) and point massage (PM)
Trial: 11494446
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy (MT), point massage (PM), and bioresonance therapy (BRT)
Trial: 3279083
Drug: Econazole cream
RxNorm normalized name: econazole Topical Cream
DrugBank: Econazole (DB01127)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Econazole cream 1%
Trial: 29742708
Drug: Mokhuri treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mokhuri treatment program (Chuna, acupuncture, patient education)
Trial: 29742708
Drug: Conventional nonsurgical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional nonsurgical treatments (drugs for pain relief, epidural steroid injections, physical therapy)
Trial: 27465912
Drug: Elcatonin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elcatonin (20 units, weekly intramuscular injections)
Trial: 27465912
Drug: NSAIDs (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (oral nonsteroidal anti-inflammatory drugs)
Trial: 24195205
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (specific points: Sishenzhen, Zhisanzhen, Niesanzhen, Naosanzhan) for 4 months
Trial: 24195205
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (piracetam tablets) for 4 months
Trial: 21518561
Drug: Guideline for
RxNorm normalized name: LARYNGEAL GUIDEWIRE,PROVOX #7215
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline for the appropriate use of antibiotics in CABG during the perioperative period
Trial: 16961161
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ketoconazole once daily on Days 1 - 4 and 5 mg SPP301 on Day 3
Trial: 16961161
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg SPP301 administered alone
Trial: 15093636
Drug: Surodex dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Surodex dexamethasone anterior segment drug delivery system
Trial: 9248770
Drug: Oral artemether
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral artemether (300 mg)
Trial: 9248770
Drug: Intramuscular artemether
RxNorm normalized name: Artemether
DrugBank: Artemether (DB06697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular artemether (300 mg)
Trial: 9248770
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of oral vs intramuscular artemether
Trial: 2129004
Drug: Alternating therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating therapy with MMC and BCG (Bacillus Calmette-Guérin)
Trial: 361060
Drug: Diflucortolone valerate
RxNorm normalized name: diflucortolone valerate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diflucortolone valerate 0.3% ointment
Trial: 15749316
Drug: Three-day course
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-day course of intravenous antibiotic prophylaxis with ampicillin and netilmicin (two daily doses for 72 h)
Trial: 15749316
Drug: Single bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single bolus injection of intravenous antibiotic prophylaxis with ampicillin and netilmicin on admission
Trial: 15749316
Drug: Three-day course
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-day course of intravenous antibiotic prophylaxis with ampicillin and netilmicin
Trial: 12131109
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion at a rate to achieve a target plasma concentration of 0.5 microg/ml
Trial: 1858501
Drug: vitamin mineral
RxNorm normalized name: Multimineral/Multivitamin Oral Tablet [MULTI-VITAMIN MINERAL/BETA CAROTENE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vitamin mineral pill with a high iron content
Trial: 1858501
Drug: vitamin‐mineral pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vitamin‐mineral pill
Trial: 6353397
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg fenoterol via Hudson nebulizer
Trial: 6353397
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg salbutamol via Hudson nebulizer
Trial: 28625505
Drug: S-amlodipine nicotinate/olmesartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-amlodipine nicotinate/olmesartan medoxomil 5/40 mg (test product)
Trial: 28625505
Drug: Amlodipine besylate/olmesartan
RxNorm normalized name: Amlodipine Besylate/Olmesartan Medoxomil 5 MG-20 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine besylate/olmesartan medoxomil 10/40 mg (reference product)
Trial: 19816505
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with olmesartan medoxomil (OLM) 20 mg plus azelnidipine (AZL) 16 mg (O/A (20/16))
Trial: 19816505
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with olmesartan medoxomil (OLM) 10 mg plus azelnidipine (AZL) 8 mg (O/A (10/8))
Trial: 19816505
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with olmesartan medoxomil (OLM) 20 mg (OLM (20))
Trial: 19816505
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with azelnidipine (AZL) 16 mg (AZL (16))
Trial: 15630900
Drug: Heterozygous AAT
RxNorm normalized name: ARO-AAT
DrugBank: Fazirsiran (DB17891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heterozygous AAT variants (MZ, MS, MF, ML, ME)
Trial: 11378833
Drug: MPA 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPA 2.5 mg
Trial: 11378833
Drug: MPA 5
RxNorm normalized name: MPA
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPA 5 mg
Trial: 11378833
Drug: MPA 10
RxNorm normalized name: Fycompa 10mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPA 10 mg
Trial: 11378833
Drug: MPA 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPA 2.5 mg, MPA 5 mg, MPA 10 mg
Trial: 3989036
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml Gastrografin
Trial: 3989036
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml Gastrografin
Trial: 3989036
Drug: dilute barium
RxNorm normalized name: barium
DrugBank: Barium (DB12481)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dilute barium (600 ml)
Trial: 30868829
Drug: Qingying Tang,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingying Tang, 150 mL/time, twice a day for 12 weeks
Trial: 30868829
Drug: Acitretin Capsules,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin Capsules, 10 mg/time, twice a day for 12 weeks
Trial: 24676931
Drug: Vorapaxar 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar 2.5 mg daily
Trial: 20462978
Drug: TS-1 (40-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TS-1 (40-60 mg twice daily for 28 consecutive days, followed by a 14-day rest period)
Trial: 20462978
Drug: Taxanes (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxanes (docetaxel 60-75 mg/m(2) at 3- or 4-week intervals, paclitaxel 175 mg/m(2) at 3- or 4-week intervals or paclitaxel 80-100 mg/m(2) weekly, followed by a 1-week rest period)
Trial: 16194646
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of elemental iron (liquid ferrous gluconate) for 60 days
Trial: 16194646
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of ferrous calcium citrate tablets for 60 days
Trial: 16194646
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of iron for 60 days (control group)
Trial: 26639678
Drug: Sublingual buprenorphine/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual buprenorphine/naloxone (BNX)
Trial: 26639678
Drug: Oral naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naltrexone (NTX)
Trial: 18647128
Drug: CBGT+EX (exercise-enhanced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBGT+EX (exercise-enhanced cognitive behavioural group therapy)
Trial: 18647128
Drug: CBGT+ED (usual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBGT+ED (usual cognitive behavioural group therapy plus nutrition education)
Trial: 16948354
Drug: Montelukast, 5-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast, 5-mg tablets for 1 month
Trial: 16948354
Drug: Montelukast, before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast, before treatment
Trial: 8824057
Drug: Amitriptyline (AMI),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (AMI), 5 mg/kg per day
Trial: 31092695
Drug: ACCi-1 (acetyl-CoA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACCi-1 (acetyl-CoA carboxylase inhibitor), dosed orally for 2 weeks
Trial: 31092695
Drug: ACCi-1 (acetyl-CoA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACCi-1 (acetyl-CoA carboxylase inhibitor)
Trial: 25230962
Drug: Intracameral dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intracameral dexamethasone (0.4 mg/0.1 ml)